-
Something wrong with this record ?
Structural basis for allosteric regulation of human phosphofructokinase-1
EM. Lynch, H. Hansen, L. Salay, M. Cooper, S. Timr, JM. Kollman, BA. Webb
Language English Country England, Great Britain
Document type Journal Article
Grant support
P20GM144230
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
S10OD023476
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
S10 OD023476
NIH HHS - United States
P20 GM144230
NIGMS NIH HHS - United States
R35 GM149542
NIGMS NIH HHS - United States
1R35GM149542
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
NLK
Directory of Open Access Journals
from 2015
Free Medical Journals
from 2010
Nature Open Access
from 2010-12-01
PubMed Central
from 2012
Europe PubMed Central
from 2012
ProQuest Central
from 2010-01-01
Open Access Digital Library
from 2015-01-01
Open Access Digital Library
from 2015-01-01
Medline Complete (EBSCOhost)
from 2012-11-01
Health & Medicine (ProQuest)
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
Springer Nature OA/Free Journals
from 2010-12-01
- MeSH
- Adenosine Triphosphate * metabolism MeSH
- Allosteric Regulation MeSH
- Cryoelectron Microscopy MeSH
- Phosphofructokinase-1 * metabolism chemistry genetics MeSH
- Glycolysis MeSH
- Liver enzymology metabolism MeSH
- Protein Conformation MeSH
- Humans MeSH
- Models, Molecular MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Phosphofructokinase-1 (PFK1) catalyzes the rate-limiting step of glycolysis, committing glucose to conversion into cellular energy. PFK1 is highly regulated to respond to the changing energy needs of the cell. In bacteria, the structural basis of PFK1 regulation is a textbook example of allostery; molecular signals of low and high cellular energy promote transition between an active R-state and inactive T-state conformation, respectively. Little is known, however, about the structural basis for regulation of eukaryotic PFK1. Here, we determine structures of the human liver isoform of PFK1 (PFKL) in the R- and T-state by cryoEM, providing insight into eukaryotic PFK1 allosteric regulatory mechanisms. The T-state structure reveals conformational differences between the bacterial and eukaryotic enzyme, the mechanisms of allosteric inhibition by ATP binding at multiple sites, and an autoinhibitory role of the C-terminus in stabilizing the T-state. We also determine structures of PFKL filaments that define the mechanism of higher-order assembly and demonstrate that these structures are necessary for higher-order assembly of PFKL in cells.
Department of Biochemistry and Molecular Medicine West Virginia University Morgantown WV USA
Department of Biochemistry University of Washington Seattle WA USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019276
- 003
- CZ-PrNML
- 005
- 20241024111412.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41467-024-51808-6 $2 doi
- 035 __
- $a (PubMed)39183237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lynch, Eric M $u Department of Biochemistry, University of Washington, Seattle, WA, USA $1 https://orcid.org/0000000158975167
- 245 10
- $a Structural basis for allosteric regulation of human phosphofructokinase-1 / $c EM. Lynch, H. Hansen, L. Salay, M. Cooper, S. Timr, JM. Kollman, BA. Webb
- 520 9_
- $a Phosphofructokinase-1 (PFK1) catalyzes the rate-limiting step of glycolysis, committing glucose to conversion into cellular energy. PFK1 is highly regulated to respond to the changing energy needs of the cell. In bacteria, the structural basis of PFK1 regulation is a textbook example of allostery; molecular signals of low and high cellular energy promote transition between an active R-state and inactive T-state conformation, respectively. Little is known, however, about the structural basis for regulation of eukaryotic PFK1. Here, we determine structures of the human liver isoform of PFK1 (PFKL) in the R- and T-state by cryoEM, providing insight into eukaryotic PFK1 allosteric regulatory mechanisms. The T-state structure reveals conformational differences between the bacterial and eukaryotic enzyme, the mechanisms of allosteric inhibition by ATP binding at multiple sites, and an autoinhibitory role of the C-terminus in stabilizing the T-state. We also determine structures of PFKL filaments that define the mechanism of higher-order assembly and demonstrate that these structures are necessary for higher-order assembly of PFKL in cells.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a adenosintrifosfát $x metabolismus $7 D000255
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a elektronová kryomikroskopie $7 D020285
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a játra $x enzymologie $x metabolismus $7 D008099
- 650 _2
- $a molekulární modely $7 D008958
- 650 12
- $a fosfofruktokinasa-1 $x metabolismus $x chemie $x genetika $7 D010732
- 650 _2
- $a konformace proteinů $7 D011487
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hansen, Heather $u Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA
- 700 1_
- $a Salay, Lauren $u Department of Biochemistry, University of Washington, Seattle, WA, USA $1 https://orcid.org/0000000185131891
- 700 1_
- $a Cooper, Madison $u Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA $1 https://orcid.org/0000000219340916
- 700 1_
- $a Timr, Stepan $u Department of Computational Chemistry, J. Heyrovsky Institute of Physical Chemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000258244476
- 700 1_
- $a Kollman, Justin M $u Department of Biochemistry, University of Washington, Seattle, WA, USA. jkoll@uw.edu $1 https://orcid.org/0000000203505827
- 700 1_
- $a Webb, Bradley A $u Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA. bradley.webb@hsc.wvu.edu $1 https://orcid.org/0000000252992852
- 773 0_
- $w MED00184850 $t Nature communications $x 2041-1723 $g Roč. 15, č. 1 (2024), s. 7323
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39183237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111406 $b ABA008
- 999 __
- $a ok $b bmc $g 2201862 $s 1231249
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 15 $c 1 $d 7323 $e 20240825 $i 2041-1723 $m Nature communications $n Nat Commun $x MED00184850
- GRA __
- $a P20GM144230 $p U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GRA __
- $a S10OD023476 $p U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GRA __
- $a S10 OD023476 $p NIH HHS $2 United States
- GRA __
- $a P20 GM144230 $p NIGMS NIH HHS $2 United States
- GRA __
- $a R35 GM149542 $p NIGMS NIH HHS $2 United States
- GRA __
- $a 1R35GM149542 $p U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- LZP __
- $a Pubmed-20241015